MedTrace Logo

GUT-FEELINGS: Using Citizen Science for Large-Scale Prebiotic Clinical Trials for Mental Health in Adults

NCT07752823 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1000

Last updated 2026-08-07

No results posted yet for this study

Summary

The goal of this study is to evaluate the effects of different products in participants experiencing feelings of anxiety. The main question it aims to answer is:

\- Do these products affect feelings of anxiety and related wellness outcomes compared with a placebo?

Researchers will compare participants taking active products to those taking a placebo to see whether the active products influence feelings of anxiety and related outcomes, and to monitor safety.

Participants will:

* Be randomly assigned to receive either an active product or a placebo (an inactive look-alike).
* Take their assigned product or placebo without knowing which group they are in until the study is completed.
* Complete evaluations and tasks to track safety, feelings of anxiety, and related health outcomes.

Conditions

  • Sleep Disturbance
  • Stress
  • Feeling Anxious

Interventions

OTHER

Placebo Gut Feeling Control Product

Participants will use their Placebo Gut Feeling Control Product as directed for a period of 12 weeks

OTHER

Active Gut Feeling Product 1

Participants will use their Active Gut Feeling Product 1 as directed for a period of 12 weeks

OTHER

Active Gut Feeling Product 2

Participants will use their Active Gut Feeling Product 2 as directed for a period of 12 weeks

Sponsors & Collaborators

  • Radicle Science

    collaborator INDUSTRY

  • Holobiome, Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-08-20
Primary Completion
2027-08-31
Completion
2027-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07752823 on ClinicalTrials.gov